Mario Guslandi,

Title: Probiotics for chronic intestinal disorders

Biography : 

Mario Guslandi graduated in Medicine and specialized in Gastroenterology at the  State University of Milan. He has been research fellow and  Medical Assistant at the Institute of Internal Medicine of University of Milan from 1978 to 1990. In 1990 he moved to S.Raffaele Hospital of Milan, where he has been  Head of the Clinical Hepato-Gastroenterology Unit from 1991 to 2016. Since January 2017 he is Consultant  Gastroenterologist at San Raffaele Hospital.  He is also Adjunt Professor at both  the  School of Medicine and the Post-graduate School in  Gastroenterology of the S.Raffaele University of Milan. Dr Guslandi is a Fellow of the American College of Gastroenterology and a member of the British Society of Gastroentero­logy.  He is author of more than 500 scientific papers, most of which appeared in international medical journals and parti­cipated as a speaker in various international congresses and symposia.

Amr T. M. Saeb

Title: Human Microbiome: Challenges, Threats, and OpportunitiesTitle: Human Microbiome: Challenges, Threats, and Opportunities

Biography :

Prof. Saeb earned his PhD in Molecular Phylogenetics and Population Genetics from The Ohio State University, USA, in 2006. He has more than 25 years of extensive research and teaching experience in different countries. His research interest is focused on but not limited to applied bioinformatics, molecular genetics, human genetics, complex disease genetics and evolution, diabetes genetics, bacterial pathogenomics and virulence, molecular pathology, metagenomics, microbiome, microbial genetics and host-pathogen interactions, to name a few.  He delivered lectures in world-class scientific conferences held in China, the United Kingdom, Netherlands, Austria, and Spain (European Congress of Clinical Microbiology and Infectious Diseases and Welcome Genome Campus). He authored 52 total publications in international peer-review journals, mostly as first-author, and reached 444 citations and counting.  An educator and researcher skilled in designing learning programs, conducting research projects, and enriching lives.

Olaf Larsen

Title : Microbiota management: A one health perspective

Biography:

Olaf Larsen studied chemistry at the VU University Amsterdam and obtained a PhD in physics there as well. Following postdoctoral research in New York City and Amsterdam, he continued his career within industry. Olaf worked for ASML, TNO and as a consultant life sciences within various organizations. Since 2012 he is heading the Science department at Yakult Nederland B.V., and member of the Management Team. Since 2016, he is also part time Ast. Professor the VU University focusing on the valorization and computational modelling of microbiota management

Elias Hakalehto

Title : Bacteriological Intestinal Balance

Biography : 

E. Elias Hakalehto, PhD, graduated from the University of Helsinki as a microbiologist in 1983. In 1995 he received the Postgraduate Diploma in Biotechnology from Canterbury and London, U.K. He is an alumnus of University College London in biochemical engineering. His R&D company Finnoflag Oy (est.1993) has carried out over 100 projects for various industries and universities. He was nominated year 2008 as an Adjunct Professor of biotechnical microbe analytics in Kuopio (nowadays University of Eastern Finland), and an Adjunct Professor for the University of Helsinki in 2016 in microbiological agroecology. Year 2015 he became the vice president of the International Society of Environmental Indicators, chairing the global 22nd ICEI conference in Helsinki 2017. Dr. Hakalehto has edited several scientific books on microbiome, hygiene maintenance, etc. His inventions include the Portable Microbe Enrichment Unit (PMEU), Bacteriological Intestinal Balance (BIB) and novel biorefineries. He is the Fellow Member of the International Society for Development and Sustainability (ISDS) (Japan).

Chrysi Sergaki

Title: Developing global standards for the microbiome field

Biography : 

Dr Chrysi Sergaki is the interim Head of Microbiome section at the National Institute for Biological Standards and Control (NIBSC), working on microbial interactions and how to utilise them for the benefit of human health.At NIBSC, Chrysi is leading the microbiome standardisation program, with 18 World Health Organization (WHO) endorsed projects to develop International Reference Reagents for the microbiome field as well as research projects investigating the role of the microbiome in health and disease. Prior to this, Chrysi has been working at NIBSC as scientist for two years leading research projects as well as the development of reference reagents for the DNA extraction of microbiome samples and will be evaluated as candidates for the first World Health Organization Whole Cell Reference Reagents for the microbiome.Before joining the NIBSC in 2019, Chrysi completed her PhD at the University of Warwick, UK, researching microbial interactions in fungi and bacteria and their impact on the host by combining laboratory and bioinformatics approaches.

Jean-Pol Warzee

Title: Supranational Assessment of the Quality of Probiotics: Collaborative Initiative between Independent Accredited Testing Laboratories

Biography : 

With nearly 25 year’s experience in the Microbiota and Microbiotics, Jean-Pol Warzée, Medical Doctor, has participated to many research and development projects in this area in Human Health in collaboration with European Research Centers and Universities. Jean-Pol has collaborated to the development of new Microbiotics solutions and is author, co-author of many publications. Co-Founder 10 years ago of the ESLP - European Scientific League for Probiotics for 2012, Jean-Pol is also the nominated President of the ESLP.  Member of several international scientific associations, he has been Vice-President of the PRI - Pharmabiotics Research Institute from 2015 – 2017. He regularly  participates as Speaker to International Congresses related to “Probiotics Quality Control” and also gives Educational Programs related to “Microbiotics in Human Health” dedicated to Medical doctors, Pharmacists and other Health Care Professionals on international level.

Teresa-María López Díaz

Title: Antifungal activity of several Lactobacilli against some cheese spoilage mycotoxigenic Penicillium

Biography :

Dr. López-Díaz obtained her MSc (Veterinary Medicine) and her PhD (Veterinary - Food Science and Technology) from the University of León (Spain). Her PhD research was based on the identification and characterization of the microbiota of a blue cheese. Her research during several decades has been dedicated to fungi of interest in foods (identification, use and control). She currently lectures food microbiology/food composition/food biotechnology at the University of Leon (Spain). She has published various papers in peer reviewed journals.

Gaurav Kaushik

Title: Probiotics and Prebiotics

Biography :

In 2006, Gaurav Kaushik, a young and dynamic first-generation entrepreneur, set out to author a legacy. Today, under his leadership Meteoric Biopharmaceuticals Pvt. Ltd., with over 100 products across Enzymes, Probiotics, Nutraceuticals, Finished Formulations & Animal Healthcare, is a leading name in the biopharma landscape across the globe.A gold medalist in Biotechnology and an astute businessman, Gaurav has been awarded the Rastriya Udyog Ratan Award by the Council of Economic Growth & Research. He is also the recipient of the Indian Leadership Award for Industrial Development by the All-India Achievers Foundation.  More recently, under his leadership, Meteoric Biopharma has been recognized as one of the 25 Most Valuable Biopharma Companies by CEO Magazine for its uncompromised dedication to quality and investment in the latest technology. Mr. Kaushik himself was recognized amongst the 101 Most Fabulous Health Care Leaders by ET Rise & World Health & Wellness Congress.

Dr. Smita Singh

Chuan-Sheng Lin

Title: Moon Culture-To-Product® Microbiome Technology Platform: Paving The Way For State-of-the-art Microbial Products And Solutions

Biography :

Dr. Chuan-Sheng Lin obtained his BSc and MSc (Medical Technology/Microbiology) from the College of Medicine, National Taiwan University, Taiwan and his PhD (Biochemistry / Cell Biology) from Graduate Institute of Biomedical Sciences, Chang Gung University, Taiwan and was a visiting scholarship scientist of European FP7 and Orchid Project in French and UK. He previously worked for Microbiota Research Center and Center for Molecular and Clinical Immunogloy in Chang Gung University as a research scientist in microbiome and immunology fieild for transforming microbiome science into clinical and industry applications. He is currently a senior vice president of Moon (Guangzhou) Biotech Co. Ltd. responsible for Drug Discovery & Biology and leading several investigational drugs of LBPs in the filed of immuno-oncology and metabolic diseases. He has published a number of peer-reviewed articles and possessed more than 30 patents in different application areas.

Lucía Diez Gutiérrez

Title: Development Of A New Functional Ingredient Enriched With Probiotic And Bioactive Metabolites

Biography :

Lucía Diez-Gutiérrez has a degree in Biological Science by the University of Oviedo (Spain, 2012-2016). Then, she achieved a double Master´s degree in Biotechnology of Environment and Health by the University of Oviedo (Spain, 2016-2017) and an MSc Food Chain Systems by Cranfield University (United Kingdom, 2017-2018). Since 2018, she is doing her PhD thesis in Tecnalia Research & Innovation, focusing on the development of new functional foods using by- products through fermentation techniques. During this time, she has been working with probiotics trying to enhance the production of beneficial microbial metabolites known as postbiotics. Recently finished a three month period as a visitant student in Queen´s University of Belfast (United Kingdom) to assess the expression of genes involved in the postbiotic biosynthetic pathway

Joanna Sliwa Dominiak

Title: Classic microbiological standards versus flow cytometry method in probiotic and food industry

Biography :

Dr. Joanna Sliwa-Dominiak obtained her BSc (Biology) and PhD (Microbiology) from University of Szczecin (Poland), where she previously worked for twelve years as an assistant professor, researcher and environmental microbiologist. Her PhD was based on analysis of bacteriophages found in the digestive system and their presence in the aquatic environment as indicators of faecal pollution. Currently, she is a Head of Quality Control Laboratory and Microbiology Laboratory in Sanprobi, Polish company producing probiotics. Responsible for microbiological analyzes and related research projects, development of fast and effective alternatives to classical microbiology for testing the quality of probiotics using flow cytometry and molecular biology as well as organization of work in the Laboratory and implementation of the quality system in R&D and Scientific Laboratory.

Dana M Walsh

Title: Innovative Microbiome Analysis with the CosmosID-Hub and Custom Analyses

Biogrphy :

Dana Walsh is a microbiome scientist whose career has consisted of a blend of wet bench and computational research. Currently, she is a Microbiome Scientist for CosmosID where she helps clients with custom microbiome analysis as well as exploring new tools and methods for microbiome studies. In her last role at Rebiotix she focused on the analysis and evaluation of complex microbiome data supporting the development of microbiome-based live biotherapeutic drugs. Here, she applied novel analysis methods to derive meaning from microbial taxonomic, functional, and metabolomic data. She completed a postdoctoral fellowship at Mayo Clinic in Rochester, Minnesota (USA), where she investigated the role of the microbiome in cancers of the reproductive tract, including ovarian and endometrial cancer. She received her PhD from the University of North Carolina in Chapel Hill, where she studied the impact of inhaled toxins on the airway microbiome in victims of burn and inhalation injury.

Dana Buckman

Title: How are we affecting the health of probiotics

Erika Gilmandinova

Title: Probiotic Kefir to improve the brain, gut and immune system

Erika and Dario founded Kefir Lab as part of their shared vision to revolutionize the world’s perspective on having a healthy gut. Erika grow up in Moscow, Russia surrounded by family generation of doctors where she learned about the gut-brain connection and the incredible benefits probiotic Kefir has on our bodies. When she moved to North America she couldn’t find the high quality probiotic Kefir that met her expectations, where the origins of Kefir date back to 2,000 years. After experiencing drastic changes on the way she feels and performs she knew she could do much better and started to experiment making her own Kefir using the biomedical approach she learned from her father. Dario grew up in Tuscany, Italy, where he cultivated his passion about the art of real and healthy food. While in North America’s restaurant business, Dario experienced the negative effect that processed food and antibiotics have on our immune system, inflammation and overall health. Motivated by Erika’s passion in Probiotic Kefir, numerous readings and self-experiments - he felt the real difference and thrived to share it with the world!

After years of probiotic research and traveling in search of the highest quality ingredients Erika and Dario crafted the markets most functional probiotic Kefir in their Laboratory ensuring the maximum benefits for our biome. Ever since, we are honored to hear our customers transformational journeys with Kefir Lab Probiotics. We are dedicated to placing people first, delivering value, working sustainable and maintaining extremely high production standards in our Laboratory.

YEON-JU KIM

Title: Immune-enhancing efficacy of Curtobacterium proimmune K3 lysates isolated from Panax ginseng beverages in cyclophosphamide-induced immunosuppressed mice

Dr Mehdi Ali Mirza

Title: Safety and Efficacy of Bacillus clausii UBBC07 and Bacillus coagulans Unique IS-2 Spores as Add-on to Standard Therapy to Study the Progress of SARS-cov-2 Infection in Patients with Moderate Symptoms of COVID-19

Biography :

Dr.Mehdi Ali Mirza obtained his MBBS degree from the Nanjing Medical University, Nanjing, Jiangsu Province, P.R.China. He has previously worked in Emergency and Accidents as a resident doctor and also in Oncology department as medical officer. His MD (Pharmacology) and DM (Clinical Pharmacology and Therapeutics) thesis works were based on decreasing severity of adverse effects of various cancer treatment modalities such as chemotherapy and radiation therapy. The work comprises amelioration of radiation therapy induced skin burns and oral mucositis, high dose methotrexate toxicities in hypoalbuminimic acute lympholatic leukemia patients He is currently serving as assistant professor in the department of Pharmacology, at ESIC Medical College and Hospital, Hyderabad, India and guiding both medical graduates and post-graduates. His areas of interest are drug development & clinical trials, safe cancer chemotherapy, virtual trials and remote patient monitoring, discover the promising roles of probiotics. She has published various papers in peer reviewed journals.

Jonathan Tanaka

Title: Choosing your scientific and regulatory game-changer probiotics and postbiotics

Biography :

Jonathan has earned two undergraduate degrees, BS in Biology and BA in Cognitive Psychology from the University of California, San Diego. He also holds a MS in Biological Sciences from the California State University, Fullerton and has completed post graduate work on neuro-cognitive imaging at the University of California, Irvine School of Medicine. Jonathan is currently pursuing a Ph.D. in Clinical Sciences. Professionally, he has worked in research, quality, and regulatory matters for 15+ years

Dr. Mithilesh Jaiswal

Title: Beneficial for Health and Carrier

Dr. Manorama Patri

Title: Microbiome-Linked Crosstalk in the Gastrointestinal Exposome towards Mental Health

Biography: 

Dr. Patri is working as an Assistant Professor at Department of Zoology, Ravenshaw University since 2011. She has 20 years of teaching and more than 16 years of research experience in the field of Cognitive Neuroscience. She has completed her PhD in the year 2000 from Sambalpur University. She worked as the Post-Doctoral Fellow in Human Stress Signal Research Center (HSS), Advanced Industrial Science and Technology (AIST), Kansai Center, Japan on “Stress and Neuro-Developmental Disorders”.  She worked in the Central University of Hyderabad on “Stem cell therapy” in the Department of Animal Science and then moved to Neurobiology Laboratory of Prof. B.N. Mallick at Jawaharlal Nehru University, New Delhi, as a Women Scientist (DST, WOS “A”) Fellow and worked on “Cellular and Molecular Mechanism of Learning and Memory”. She has published more than 45 papers in peer reviewed journals and authored 10 text books and 03 book chapters. She is a life member of Indian Academy of Neuroscience (IAN), Society for Neurochemistry, India (SNCI) and Odisha Bigyan Academy (OBA). Her current research interest mainly focuses on gut microbiota and their interaction with brain, resulting changes in central nervous system function and cognitive behavior.

Duresa CETAKU-FRITZ

Maggie Belshé

Title: Probiotic and herbal blend decreases markers of inflammation in in vitro and in vivo models of proteobacteria-induced dysbiosis

Biography:

Maggie Belshé is Chief Customer Officer of ResBiotic Nutrition, Inc, a consumer health company focused on developing probiotics for lung health. ResBiotic was founded by physician scientists based on over a decade of research at the intersections of respiratory and microbiome science. The resB formulation was encapsulated to create their first product, resB Lung Support. The company is also conducting human clinical studies for resB Lung Support, the first of which was completed in January 2022 with promising results (pending publication).

C. Vivek Lal

Title: Probiotic and herbal blend decreases markers of inflammation in in vitro and in vivo models of proteobacteria-induced dysbiosis

Redife Aslihan UCAR

Heather Holmes